ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1 clini ...

ATXD29A , intersected Early Porphyry, below the previously reported B2B interval, hitting 104 metres ( " m " ) of 1.06% ...

MESA, ARIZONA / ACCESS Newswire / July 17, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to announce that all three of its divisions are currently experiencing their most dynamic an ...

Utah GOP nominates 3 conservative finalists for seat on state school board Gov. Spencer Cox will ultimately choose which of the three will replace former state board member Molly Hart after she ...

Topline results were announced from a phase 3 study evaluating secukinumab in adults with newly diagnosed or relapsing giant cell arteritis (GCA).

BioXcel Therapeutics Receives Second Positive Recommendation from Data Safety Monitoring Board (DSMB) to Continue SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation ...

The future of San Francisco’s Mexican Museum is in jeopardy after the beleaguered organization missed a key fundraising deadline for the construction of its long-gestating downtown location. The ...

The Arkansas State Board of Election Commissioners voted to decertify all three Searcy County election commissioners for a period of 14 years, the maximum amount of time, after finding that ...

The phase 3 IRAKLIA trial assesses subcutaneous isatuximab via on-body injector vs intravenous (IV) administration, in combination with pomalidomide and dexamethasone, in relapsed/refractory ...

With what Insmed calls an "outstanding" phase 2 win for its treprostinil palmitil inhalation powder (TPIP) in patients with pulmonary arterial hypertension (PAH), the company is racing to phase 3 ...

Denifanstat showed positive Phase 3 results in acne, meeting all goals with strong safety, as Sagimet pushes ahead with a second FASN inhibitor trial.